Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**TC Cream** is a topical botanical drug consisting of a total-coumarin fraction purified from *Cnidium monnieri* plant extract. It is being developed for psoriasis vulgaris by HiST Pharma and its Psoriasis Research Institute of Guangzhou subsidiary. The product was evaluated in the completed 88-patient Phase IIb PLANTCOAT-IIb study and is in the registered Phase III PLANTCOAT-III study for psoriasis vulgaris. Public abstracts describe it as having obtained an NDA approval for manufacturing in China; this should not be interpreted as U.S. marketing approval. ([clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03372811))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on TC Cream.